Amgen Inc.
PEPTIDE PAC1 ANTAGONISTS

Last updated:

Abstract:

Novel peptides that bind to human PAC1 are provided. These peptides that are antagonists of PAC1 are useful in a number of PAC1 related disorders, including the treatment and/or prevention of headache disorders, including migraine, such as acute migraine.

Status:
Application
Type:

Utility

Filling date:

1 Jun 2018

Issue date:

23 Dec 2021